Loading…
Different inhibitory potential of sex hormones on NNK detoxification in vitro: A possible explanation for gender-specific lung cancer risk
Smoking women are probably at a higher risk to develop lung cancer than men. Different explanations exist for these findings, a gender-specific impairment of tobacco carcinogen metabolism being one of them. In this study, we examined the inhibition of NNK reduction to NNAL, the first and most import...
Saved in:
Published in: | Cancer letters 2017-10, Vol.405, p.120-126 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c390t-d63bbc8f17330329bb3543422959c76eb3b037b8aa051c9da0f2a278f5965c663 |
---|---|
cites | cdi_FETCH-LOGICAL-c390t-d63bbc8f17330329bb3543422959c76eb3b037b8aa051c9da0f2a278f5965c663 |
container_end_page | 126 |
container_issue | |
container_start_page | 120 |
container_title | Cancer letters |
container_volume | 405 |
creator | Stapelfeld, Claudia Neumann, Karolina-Theresa Maser, Edmund |
description | Smoking women are probably at a higher risk to develop lung cancer than men. Different explanations exist for these findings, a gender-specific impairment of tobacco carcinogen metabolism being one of them. In this study, we examined the inhibition of NNK reduction to NNAL, the first and most important detoxication step of this tobacco-specific carcinogen. It is mediated by different carbonyl reductases of the SDR (CBR1 and 11βHSD1) and AKR (AKR1B10, AKR1C1, AKR1C2 and AKR1C4) superfamilies. Inhibition constants of NNK reduction were determined with male (testosterone) and female (estradiol, progesterone) sex hormones and the contraceptives ethinylestradiol and drospirenone in A549 cells and with purified enzymes. Female sex hormones turned out to be stronger inhibitors than testosterone. The gestagen progesterone and its synthetic derivative drospirenone are the strongest inhibitors with Ki-values similar to hormone levels in pregnant women or women using hormonal contraceptives. Therefore, pregnancy or hormonal contraception may commit these women as high risk groups. The results of this study support the hypothesis that women bear a higher lung cancer risk when smoking because of female sex hormones acting as inhibitors of NNK detoxication. |
doi_str_mv | 10.1016/j.canlet.2017.07.016 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1923740672</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383517304512</els_id><sourcerecordid>1923740672</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-d63bbc8f17330329bb3543422959c76eb3b037b8aa051c9da0f2a278f5965c663</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi0EokvhDRCyxIVLlrGdxAkHpKr8FVW5wNlynHHrJWsH26m2z8BL8Cw8GY62cOCANJKl0e8bfzMfIU8ZbBmw9uVua7SfMG85MLmFUqy9Rzask7ySfQf3yQYE1JXoRHNCHqW0A4Cmls1DcsI7WYtGwIb8eOOsxYg-U-ev3eByiLd0Drl0nJ5osDThgV6HuA8eEw2eXl5-oiPmcHDWGZ1daTn_6-eNyzG8omdFnJIbJqR4mCftj4QNkV6hHzFWaUazSum0-CtaljAYaXTp22PywOop4ZO795R8fff2y_mH6uLz-4_nZxeVET3kamzFMJjOMikECN4Pg2hqUXPeN72RLQ5iACGHTmtomOlHDZZrLjvb9G1j2lackhfHuXMM3xdMWe1dMjgVsxiWpFjPhayhlbygz_9Bd2GJvrgrVLmg7ABWqj5SJpbdI1o1R7fX8VYxUGtYaqeOYak1LAWl2Orj2d3wZdjj-Ff0J50CvD4CWK5x4zCqZByWe40uoslqDO7_P_wGfqypcA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1935378002</pqid></control><display><type>article</type><title>Different inhibitory potential of sex hormones on NNK detoxification in vitro: A possible explanation for gender-specific lung cancer risk</title><source>ScienceDirect Freedom Collection</source><creator>Stapelfeld, Claudia ; Neumann, Karolina-Theresa ; Maser, Edmund</creator><creatorcontrib>Stapelfeld, Claudia ; Neumann, Karolina-Theresa ; Maser, Edmund</creatorcontrib><description>Smoking women are probably at a higher risk to develop lung cancer than men. Different explanations exist for these findings, a gender-specific impairment of tobacco carcinogen metabolism being one of them. In this study, we examined the inhibition of NNK reduction to NNAL, the first and most important detoxication step of this tobacco-specific carcinogen. It is mediated by different carbonyl reductases of the SDR (CBR1 and 11βHSD1) and AKR (AKR1B10, AKR1C1, AKR1C2 and AKR1C4) superfamilies. Inhibition constants of NNK reduction were determined with male (testosterone) and female (estradiol, progesterone) sex hormones and the contraceptives ethinylestradiol and drospirenone in A549 cells and with purified enzymes. Female sex hormones turned out to be stronger inhibitors than testosterone. The gestagen progesterone and its synthetic derivative drospirenone are the strongest inhibitors with Ki-values similar to hormone levels in pregnant women or women using hormonal contraceptives. Therefore, pregnancy or hormonal contraception may commit these women as high risk groups. The results of this study support the hypothesis that women bear a higher lung cancer risk when smoking because of female sex hormones acting as inhibitors of NNK detoxication.</description><identifier>ISSN: 0304-3835</identifier><identifier>ISSN: 1872-7980</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2017.07.016</identifier><identifier>PMID: 28743530</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>17β-Estradiol ; 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) ; Carbonyl reduction ; Carcinogens ; Carcinogens - metabolism ; Contraception ; Contraceptives ; Detoxification ; Enzymes ; Ethinylestradiol ; Female ; Gender ; Gonadal Steroid Hormones - pharmacology ; Health risk assessment ; Health risks ; Hormone replacement therapy ; Humans ; Inhibition ; Inhibitors ; Liver - drug effects ; Lung cancer ; Lung Neoplasms - metabolism ; Lungs ; Male ; Metabolism ; Nitrosamines - metabolism ; Pregnancy ; Progesterone ; Pyridines - metabolism ; Reductases ; Risk groups ; Sex ; Sex Factors ; Sex hormones ; Sexes ; Smoking ; Smoking - adverse effects ; Testosterone ; Tobacco ; Tobacco Products ; Tumor Cells, Cultured ; Womens health</subject><ispartof>Cancer letters, 2017-10, Vol.405, p.120-126</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Limited Oct 1, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-d63bbc8f17330329bb3543422959c76eb3b037b8aa051c9da0f2a278f5965c663</citedby><cites>FETCH-LOGICAL-c390t-d63bbc8f17330329bb3543422959c76eb3b037b8aa051c9da0f2a278f5965c663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28743530$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stapelfeld, Claudia</creatorcontrib><creatorcontrib>Neumann, Karolina-Theresa</creatorcontrib><creatorcontrib>Maser, Edmund</creatorcontrib><title>Different inhibitory potential of sex hormones on NNK detoxification in vitro: A possible explanation for gender-specific lung cancer risk</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Smoking women are probably at a higher risk to develop lung cancer than men. Different explanations exist for these findings, a gender-specific impairment of tobacco carcinogen metabolism being one of them. In this study, we examined the inhibition of NNK reduction to NNAL, the first and most important detoxication step of this tobacco-specific carcinogen. It is mediated by different carbonyl reductases of the SDR (CBR1 and 11βHSD1) and AKR (AKR1B10, AKR1C1, AKR1C2 and AKR1C4) superfamilies. Inhibition constants of NNK reduction were determined with male (testosterone) and female (estradiol, progesterone) sex hormones and the contraceptives ethinylestradiol and drospirenone in A549 cells and with purified enzymes. Female sex hormones turned out to be stronger inhibitors than testosterone. The gestagen progesterone and its synthetic derivative drospirenone are the strongest inhibitors with Ki-values similar to hormone levels in pregnant women or women using hormonal contraceptives. Therefore, pregnancy or hormonal contraception may commit these women as high risk groups. The results of this study support the hypothesis that women bear a higher lung cancer risk when smoking because of female sex hormones acting as inhibitors of NNK detoxication.</description><subject>17β-Estradiol</subject><subject>4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)</subject><subject>Carbonyl reduction</subject><subject>Carcinogens</subject><subject>Carcinogens - metabolism</subject><subject>Contraception</subject><subject>Contraceptives</subject><subject>Detoxification</subject><subject>Enzymes</subject><subject>Ethinylestradiol</subject><subject>Female</subject><subject>Gender</subject><subject>Gonadal Steroid Hormones - pharmacology</subject><subject>Health risk assessment</subject><subject>Health risks</subject><subject>Hormone replacement therapy</subject><subject>Humans</subject><subject>Inhibition</subject><subject>Inhibitors</subject><subject>Liver - drug effects</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - metabolism</subject><subject>Lungs</subject><subject>Male</subject><subject>Metabolism</subject><subject>Nitrosamines - metabolism</subject><subject>Pregnancy</subject><subject>Progesterone</subject><subject>Pyridines - metabolism</subject><subject>Reductases</subject><subject>Risk groups</subject><subject>Sex</subject><subject>Sex Factors</subject><subject>Sex hormones</subject><subject>Sexes</subject><subject>Smoking</subject><subject>Smoking - adverse effects</subject><subject>Testosterone</subject><subject>Tobacco</subject><subject>Tobacco Products</subject><subject>Tumor Cells, Cultured</subject><subject>Womens health</subject><issn>0304-3835</issn><issn>1872-7980</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQxi0EokvhDRCyxIVLlrGdxAkHpKr8FVW5wNlynHHrJWsH26m2z8BL8Cw8GY62cOCANJKl0e8bfzMfIU8ZbBmw9uVua7SfMG85MLmFUqy9Rzask7ySfQf3yQYE1JXoRHNCHqW0A4Cmls1DcsI7WYtGwIb8eOOsxYg-U-ev3eByiLd0Drl0nJ5osDThgV6HuA8eEw2eXl5-oiPmcHDWGZ1daTn_6-eNyzG8omdFnJIbJqR4mCftj4QNkV6hHzFWaUazSum0-CtaljAYaXTp22PywOop4ZO795R8fff2y_mH6uLz-4_nZxeVET3kamzFMJjOMikECN4Pg2hqUXPeN72RLQ5iACGHTmtomOlHDZZrLjvb9G1j2lackhfHuXMM3xdMWe1dMjgVsxiWpFjPhayhlbygz_9Bd2GJvrgrVLmg7ABWqj5SJpbdI1o1R7fX8VYxUGtYaqeOYak1LAWl2Orj2d3wZdjj-Ff0J50CvD4CWK5x4zCqZByWe40uoslqDO7_P_wGfqypcA</recordid><startdate>20171001</startdate><enddate>20171001</enddate><creator>Stapelfeld, Claudia</creator><creator>Neumann, Karolina-Theresa</creator><creator>Maser, Edmund</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20171001</creationdate><title>Different inhibitory potential of sex hormones on NNK detoxification in vitro: A possible explanation for gender-specific lung cancer risk</title><author>Stapelfeld, Claudia ; Neumann, Karolina-Theresa ; Maser, Edmund</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-d63bbc8f17330329bb3543422959c76eb3b037b8aa051c9da0f2a278f5965c663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>17β-Estradiol</topic><topic>4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)</topic><topic>Carbonyl reduction</topic><topic>Carcinogens</topic><topic>Carcinogens - metabolism</topic><topic>Contraception</topic><topic>Contraceptives</topic><topic>Detoxification</topic><topic>Enzymes</topic><topic>Ethinylestradiol</topic><topic>Female</topic><topic>Gender</topic><topic>Gonadal Steroid Hormones - pharmacology</topic><topic>Health risk assessment</topic><topic>Health risks</topic><topic>Hormone replacement therapy</topic><topic>Humans</topic><topic>Inhibition</topic><topic>Inhibitors</topic><topic>Liver - drug effects</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - metabolism</topic><topic>Lungs</topic><topic>Male</topic><topic>Metabolism</topic><topic>Nitrosamines - metabolism</topic><topic>Pregnancy</topic><topic>Progesterone</topic><topic>Pyridines - metabolism</topic><topic>Reductases</topic><topic>Risk groups</topic><topic>Sex</topic><topic>Sex Factors</topic><topic>Sex hormones</topic><topic>Sexes</topic><topic>Smoking</topic><topic>Smoking - adverse effects</topic><topic>Testosterone</topic><topic>Tobacco</topic><topic>Tobacco Products</topic><topic>Tumor Cells, Cultured</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stapelfeld, Claudia</creatorcontrib><creatorcontrib>Neumann, Karolina-Theresa</creatorcontrib><creatorcontrib>Maser, Edmund</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stapelfeld, Claudia</au><au>Neumann, Karolina-Theresa</au><au>Maser, Edmund</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Different inhibitory potential of sex hormones on NNK detoxification in vitro: A possible explanation for gender-specific lung cancer risk</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2017-10-01</date><risdate>2017</risdate><volume>405</volume><spage>120</spage><epage>126</epage><pages>120-126</pages><issn>0304-3835</issn><issn>1872-7980</issn><eissn>1872-7980</eissn><abstract>Smoking women are probably at a higher risk to develop lung cancer than men. Different explanations exist for these findings, a gender-specific impairment of tobacco carcinogen metabolism being one of them. In this study, we examined the inhibition of NNK reduction to NNAL, the first and most important detoxication step of this tobacco-specific carcinogen. It is mediated by different carbonyl reductases of the SDR (CBR1 and 11βHSD1) and AKR (AKR1B10, AKR1C1, AKR1C2 and AKR1C4) superfamilies. Inhibition constants of NNK reduction were determined with male (testosterone) and female (estradiol, progesterone) sex hormones and the contraceptives ethinylestradiol and drospirenone in A549 cells and with purified enzymes. Female sex hormones turned out to be stronger inhibitors than testosterone. The gestagen progesterone and its synthetic derivative drospirenone are the strongest inhibitors with Ki-values similar to hormone levels in pregnant women or women using hormonal contraceptives. Therefore, pregnancy or hormonal contraception may commit these women as high risk groups. The results of this study support the hypothesis that women bear a higher lung cancer risk when smoking because of female sex hormones acting as inhibitors of NNK detoxication.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>28743530</pmid><doi>10.1016/j.canlet.2017.07.016</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0304-3835 |
ispartof | Cancer letters, 2017-10, Vol.405, p.120-126 |
issn | 0304-3835 1872-7980 1872-7980 |
language | eng |
recordid | cdi_proquest_miscellaneous_1923740672 |
source | ScienceDirect Freedom Collection |
subjects | 17β-Estradiol 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) Carbonyl reduction Carcinogens Carcinogens - metabolism Contraception Contraceptives Detoxification Enzymes Ethinylestradiol Female Gender Gonadal Steroid Hormones - pharmacology Health risk assessment Health risks Hormone replacement therapy Humans Inhibition Inhibitors Liver - drug effects Lung cancer Lung Neoplasms - metabolism Lungs Male Metabolism Nitrosamines - metabolism Pregnancy Progesterone Pyridines - metabolism Reductases Risk groups Sex Sex Factors Sex hormones Sexes Smoking Smoking - adverse effects Testosterone Tobacco Tobacco Products Tumor Cells, Cultured Womens health |
title | Different inhibitory potential of sex hormones on NNK detoxification in vitro: A possible explanation for gender-specific lung cancer risk |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A58%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Different%20inhibitory%20potential%20of%20sex%20hormones%20on%20NNK%20detoxification%20in%C2%A0vitro:%20A%20possible%20explanation%20for%20gender-specific%20lung%20cancer%20risk&rft.jtitle=Cancer%20letters&rft.au=Stapelfeld,%20Claudia&rft.date=2017-10-01&rft.volume=405&rft.spage=120&rft.epage=126&rft.pages=120-126&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2017.07.016&rft_dat=%3Cproquest_cross%3E1923740672%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c390t-d63bbc8f17330329bb3543422959c76eb3b037b8aa051c9da0f2a278f5965c663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1935378002&rft_id=info:pmid/28743530&rfr_iscdi=true |